Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 24 citing Barzilay: Baseline characteristics of the diabetic participants in the Antihypertensive and.... (0.09 sec) 

Clinical trials and lipid guidelines for type II diabetes


LM Prisant - The Journal of Clinical Pharmacology, 2004 - jclinpharm.highwire.org
The management of dyslipidemia in adults with diabetes is receiving more attention.
However, there is a paucity of large, prospective, randomized outcome trials designed for diabetic
patients. Diabetic dyslipidemia is characterized by an increase in triglyceride levels, low ...
Cited by 50 - Related articles - BL Direct - All 6 versions

Diabetes, hypertension, and cardiovascular derangements: pathophysiology and …


F El-Atat, SI McFarlane, JR Sowers - Current Hypertension Reports, 2004 - Springer
Pathogenesis of Hypertension in Insulin Resistance/Hyperinsulinemia and Diabetes The association
of hypertension, INS resistance, and resultant hyperinsulinemia is well established [1,3–6,8–16
,17••,18– 21,22•,23,24,25••,26–32]. In untreated essential hyperten- sive patients, fasting ...
Cited by 47 - Related articles - BL Direct - All 3 versions

Glucose, blood pressure, and lipid control in older people with and without …


NL Smith, PJ Savage, SR Heckbert, JI … - Journal of the …, 2002 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 44 - Related articles - BL Direct - All 4 versions

Hypertension and diabetes


K Jandeleit-Dahm, ME Cooper - Current opinion in nephrology and …, 2002 - journals.lww.com
Hypertension is often associated clinically with diabetes either as part of the insulin resistance
syndrome or as a manifestation of renal disease. Elevated systemic blood pressure accelerates
the progression of both microvascular and macrovascular complications in diabetes. ...
Cited by 43 - Related articles - BL Direct - All 5 versions

Hypertension in the Elderly: Can We Improve Results of Therapy?

- washington.edu [PDF] 
LM Prisant, M Moser - Archives of Internal Medicine, 2000 - Am Med Assoc
Awareness of and therapy for hypertension in the United States have been increasing in older
patients. Despite this improvement, hypertension continues to be poorly controlled in this patient
population. The control rate, defined as systolic blood pressure less than 140 mm Hg and ...
Cited by 38 - Related articles - BL Direct - All 11 versions

Hypertension prevalence, awareness, treatment, and control in an adult type 1 …

- diabetesjournals.org
DM Maahs, GL Kinney, P Wadwa, JK Snell- … - Diabetes Care, 2005 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—In 2000–2002, the Coronary Artery Calcification in Type
1 Diabetes Study enrolled 1,416 individuals aged 19–56 years with no known history of coronary
artery disease: 652 type 1 diabetic patients (46% male, mean age 37 years) and 764 ...
Cited by 32 - Related articles - All 7 versions

Diabetes and heart disease: an evidence-driven guide to risk factors management …


AA Lteif, KJ Mather, CM Clark - Cardiology in Review, 2003 - journals.lww.com
Type 2 diabetes is a worldwide epidemic. Cardio- vascular diseases remain the major cause
of death in patients with diabetes, partly because of the association of diabetes and the metabolic
syn- drome. In this review, we will discuss the evidence for treatment and prevention of ...
Cited by 23 - Related articles - BL Direct - All 3 versions

The expanding scope of the metabolic syndrome and implications for the …


AS Greenberg - Journal of diabetes and its complications, 2003 - Elsevier
Over the last decade, new factors including endothelial dysfunction, vascular inflammation, and
abnormalities of blood coagulation have joined more established components of the metabolic
syndrome, such as hyperglycemia, hypertension, dyslipidemia, and visceral obesity. ...
Cited by 15 - Related articles - All 13 versions

[PDF] Ethnic, gender, and age-related differences in treatment and control of …


KH Hendrix, JE Riehle, BM Egan - Ethnicity & Disease, 2005 - ishib.org
Background: Demographic differences in management of concomitant lipid disorders among
hypertensive patients may contribute to health disparities. ... Objectives: Assess demographic
differences in lipid control rates and treatment patterns among dyslipidemic hypertensive ...
Cited by 14 - Related articles - View as HTML - All 4 versions

Cardiovascular outcomes using doxazosin vs. chlorthalidone for the treatment of …


JI Barzilay, BR Davis, J Bettencourt, KL … - JOURNAL OF …, 2004 - interscience.wiley.com
The authors studied the effects of these two classes of hypertension medications (doxazosin,
an α blocker, and chlorthalidone, a diuretic) on cardiovascular disease outcomes in adults aged
>55 years with hypertension and glucose disorders who were participants in the ...
Cited by 14 - Related articles - BL Direct - All 4 versions


Result Page: 

1

2

3

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google